Configurable cloud-connected iPad controlled multimodal ophthalmic laser

Alanko, Jukka-Pekka; Kaivosoja, Visa; Baldin, Ivan; Tanila, Timo; Koivumäki, Eero; Uusimaa, Petteri; Ylöniemi, Zoe

doi:10.1117/12.2577620

Ophthalmic Technologies XXXI 2021

DOI: 10.1117/12.2577620

|View full text |Cite

Configurable cloud-connected iPad controlled multimodal ophthalmic laser

Jukka-Pekka Alanko

Visa Kaivosoja

Ivan Baldin

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Other1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Figure3. Displays the laser beams cross-sectional beam profile, x-axis and y-axis, to illustrate the high beam quality achieved from the Modulight beam shaping unit where a top-hat profile was produced [9]. …”

mentioning

confidence: 99%

Novel ophthalmic PDT laser platform to target oncology and various other retinal indications

Vesala

Koivumäki²,

Alanko³

et al. 2023

Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXXI

Self Cite

View full text Add to dashboard Cite

Laser systems, in ophthalmic applications, are utilized in the treatment of various ophthalmic diseases such as in ocular oncology and age-related macular degeneration through photochemical mechanism of photodynamic therapy. In addition, these lasers can be used to activate drug delivery systems in the retina to provide targeted drug therapy. PDT is a form of a combination treatment which utilizes light energy to activate a photoactive pharmaceutical (photosensitizer) to create a photodynamic reaction. Current photodynamic therapy devices out on the market are around 20 years old and the companies that manufacture the devices, do not provide yearly maintenance services for the devices. Therefore, Modulight has developed the multi-indication ML6710i ophthalmic laser platform and the beam shaping unit ML-SLA to address the need for supported PDT equipment and to target the treatment of oncological and various other diseases affecting the posterior of the eye with the capability to provide laser light ranging from 400 nm to 2000 nm depending on the specific customer needs. ML-SLA has been tested to yield a superior beam quality and enable a larger spot size range than any existing beam shaping unit in the market, thus eliminating the need for multi-spot treatment of larger lesions. The device connects to Modulight Cloud services, enhancing treatment planning and post-operative analysis. In addition, the ML6710i laser platform has the capability of including a camera module to record the intra-operative fundus view into Modulight Cloud to further assist in post-operative treatment analysis.

show abstract

mentioning

confidence: 99%

Novel ophthalmic PDT laser platform to target oncology and various other retinal indications

Vesala

Koivumäki²,

Alanko³

et al. 2023

Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXXI

Self Cite

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Configurable cloud-connected iPad controlled multimodal ophthalmic laser

Cited by 1 publication

References 0 publications

Novel ophthalmic PDT laser platform to target oncology and various other retinal indications

Novel ophthalmic PDT laser platform to target oncology and various other retinal indications

Contact Info

Product

Resources

About